Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 100, Topic 1
In Progress

Foundational Principles of Infection Risk in Open Fractures

Lesson Progress
0% Complete
Foundational Principles of Infection Risk in Open Fractures

Foundational Principles of Infection Risk in Open Fractures

Objectives Icon A target icon representing a learning goal.

Lesson Objective

Understand the epidemiology, pathophysiology, comorbidities, and social factors that influence infection risk in open fractures to guide early risk stratification and antibiotic planning.

1. Epidemiology and Incidence

Summary: Open fractures are uncommon but carry high infection risk, especially in critically ill trauma patients. Incidence rises with fracture severity and the mechanism of contamination.

  • Overall prevalence: Approximately 2% of all fractures; however, up to 45% of long-bone injuries in high-energy trauma may be classified as open in Level I trauma centers.
  • Gustilo-Anderson infection rates:
    • Type I: 0–2%
    • Type II: up to 10%
    • Type III (A–C): 10–50%, with the highest rates in Type IIIB/C fractures involving significant soft tissue loss and vascular injury.
  • ICU amplifiers: Risk is magnified by polytrauma, hemorrhagic shock, prolonged mechanical ventilation, the presence of invasive devices, and the development of SIRS or immunoparalysis.
  • Mechanism impacts flora:
    • Agricultural/soil contamination: Associated with gram-negatives and anaerobes.
    • Urban/blast injuries: Primarily associated with Staphylococcus aureus and coagulase-negative staphylococci.
Key Points Icon A lightbulb icon, indicating key takeaways. Key Points
  • Even Type I injuries in hypotensive or transfused ICU patients may behave like higher-grade fractures from an infection risk perspective.
  • Higher Gustilo-Anderson types and specific environmental contaminations (e.g., farm soil) predict a higher likelihood of multidrug-resistant organisms.

2. Pathophysiology of Infection Risk

Summary: Infection ensues when the breach of skin and periosteum is followed by the creation of devitalized tissue, impaired perfusion, and an inadequate host defense, creating a favorable environment for microbial colonization.

  • Soft tissue disruption: Devitalized muscle and periosteal stripping severely reduce local blood flow and oxygen delivery, impairing the immune response.
  • Microbial inoculation and biofilm: Bacteria can adhere to exposed bone and implanted hardware, forming a protective biofilm within 48–72 hours that hinders antibiotic penetration and eradication.
  • Environmental pathogens: These organisms thrive in the hypoxic, nutrient-rich pockets created by devascularized tissue.
  • Systemic critical illness alters immunity:
    • The host response is compromised by neutrophil dysfunction, reduced monocyte HLA-DR expression, and lymphopenia.
    • Capillary leak and hypoalbuminemia increase the volume of distribution (Vd) of hydrophilic antibiotics, potentially leading to subtherapeutic tissue concentrations.
Key Points Icon A lightbulb icon, indicating key takeaways. Key Points
  • The “golden window” for intervention is critical; early surgical debridement combined with optimal antibiotic pharmacokinetics/pharmacodynamics (PK/PD) before biofilm maturation is essential for prevention.
  • Clinicians must monitor volume status and serum albumin, adjusting antibiotic dosing as needed to maintain adequate tissue levels, especially in edematous or hypoalbuminemic states.

3. Impact of Pre-existing Chronic Conditions

Summary: Comorbidities such as diabetes, immunosuppression, and vascular disease each independently magnify infection risk and complicate the healing process.

  • Diabetes mellitus:
    • Hyperglycemia directly impairs neutrophil chemotaxis, phagocytosis, and oxidative burst capabilities.
    • Underlying microvascular changes further reduce wound perfusion and immune cell trafficking.
    • Targeting an ICU glucose level of 140–180 mg/dL is a key strategy for infection prevention.
  • Immunosuppression:
    • Chronic use of steroids, biologic agents, or chemotherapy blunts T-cell and cytokine responses necessary for bacterial clearance.
    • Consider broader initial antibiotic coverage and early consultation with Infectious Diseases (ID) for tailored prophylactic regimens.
  • Vascular disease:
    • Peripheral arterial disease and chronic venous insufficiency limit the delivery of oxygen, nutrients, antibiotics, and immune cells to the injury site.
    • Hyperbaric oxygen therapy has been explored in small case series but lacks definitive support from large randomized controlled trials (RCTs).
Key Points Icon A lightbulb icon, indicating key takeaways. Key Points
  • Standard prophylactic antibiotic regimens may require expansion (e.g., adding coverage for Pseudomonas) in immunocompromised hosts.
  • Prioritize the optimization of glycemic control and systemic perfusion before proceeding with definitive fracture fixation.

4. Social Determinants of Health

Summary: Barriers related to healthcare access, health literacy, and socioeconomic context can significantly delay timely antibiotics, debridement, and follow-up care, thereby increasing infection risk.

  • Access and adherence:
    • Challenges such as lack of transportation, high medication costs, and restrictive insurance formularies can interrupt or prevent completion of essential antibiotic courses.
    • Early involvement of social work and case management is crucial to secure home support, medication access, and outpatient resources before discharge.
  • Health literacy:
    • Employing “teach-back” methods and providing visual aids for wound care have been shown to reduce readmissions for wound complications.
  • Socioeconomic stability:
    • Unstable housing and the absence of a reliable caregiver can severely hinder post-ICU and post-discharge care plans.
    • Telehealth platforms and visiting home-care nursing services can help mitigate geographic and resource-related gaps in care.
Key Points Icon A lightbulb icon, indicating key takeaways. Key Points
  • Systematically document social barriers at the time of admission to trigger early referrals to case management and pharmacy support services.
  • Actively engage patients and their families in hands-on wound care education before they are discharged to improve self-efficacy and outcomes.

5. Clinical Application and Decision Points

Summary: A comprehensive approach requires integrating the fracture grade with systemic and social risk factors to triage the urgency of debridement, determine the appropriate antibiotic spectrum, and coordinate multidisciplinary referrals.

Open Fracture Infection Risk Stratification Algorithm A flowchart showing a three-step process for risk stratification. Step 1 is assessing the Gustilo-Anderson type. Step 2 is evaluating systemic factors like shock and comorbidities. Step 3 is identifying social barriers. The outcome is a comprehensive risk profile guiding therapy. 1. Assess Fracture (Gustilo-Anderson Type) 2. Evaluate Systemic Factors (Shock, Comorbidities) 3. Identify Social Barriers (Access, Literacy, Support) Clinical Factors Patient-Specific Factors
Figure 1: Risk Stratification Algorithm. A systematic approach to infection risk assessment combines objective injury characteristics with patient-specific systemic and social factors to create a holistic view that guides interventions.

Early Intervention Triggers

  • Type III injuries or known immunosuppression: Trigger an automatic Infectious Diseases (ID) consultation and consider expanded gram-negative coverage (e.g., piperacillin-tazobactam or cefepime).
  • Diabetes: Trigger a consultation with endocrinology or the inpatient glucose management team to optimize glycemic control.
  • Identified social barriers: Trigger referrals to case management for discharge planning and to pharmacy for medication access assistance.

Documentation

Use standardized risk-factor checklists in operative and ICU progress notes to ensure all team members are aware of the patient’s risk profile. Clearly communicate the rationale for prophylactic antibiotic choices to downstream teams at handoffs.

Key Points Icon A lightbulb icon, indicating key takeaways. Key Points
  • Implementing a combined clinical and social risk checklist has been shown to improve the time to first antibiotic dose by 30% or more in some trauma systems.
  • Automatic pharmacy protocol overrides for antibiotic dose adjustments (e.g., based on low albumin or changing renal function) remain center-specific and should be guided by multidisciplinary consensus and local protocols.

References

  1. Gustilo RB, Anderson JT. Prevention of infection in the treatment of 1025 open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58(4):453-458.
  2. Patzakis MJ, Harvey JP Jr, Ivler D. The role of antibiotics in the management of open fractures. J Bone Joint Surg Am. 1974;56(3):532-541.
  3. Zalavras CG. Prevention of infection in open fractures. Infect Dis Clin North Am. 2017;31(2):339-352.
  4. Court-Brown CM, Bugler KE, Clement ND, Duckworth AD, McQueen MM. The epidemiology of open fractures in adults. Injury. 2012;43(6):891-897.
  5. Appelbaum RD, Farrell MS, Gelbard RB, et al. Antibiotic prophylaxis in injury: clinical consensus document. Trauma Surg Acute Care Open. 2024;9:e001304.
  6. Hoff WS, Bonadies JA, Cachecho R, Dorlac WC. EAST practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma. 2011;70(3):751-754.
  7. Crowley DJ, Kanakaris NK, Giannoudis PV. Debridement and wound closure of open fractures: the impact of the time factor on infection rates. Injury. 2007;38(7):879-889.
  8. Chang Y, Kennedy SA, Bhandari M, et al. Effects of antibiotic prophylaxis in patients with open fracture of the extremities: systematic review. JBJS Rev. 2015;3(1):e2.